These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6361740)

  • 21. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole.
    Jeng S; Chanchairujira T; Jusko W; Steiner R
    Transplantation; 2003 Mar; 75(6):792-5. PubMed ID: 12660503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
    Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of sirolimus in kidney transplant patients.
    Ferron GM; Mishina EV; Zimmerman JJ; Jusko WJ
    Clin Pharmacol Ther; 1997 Apr; 61(4):416-28. PubMed ID: 9129559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
    Clin Pharmacol Ther; 2004 May; 75(5):434-47. PubMed ID: 15116056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
    Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
    Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril.
    Bevan EG; McInnes GT; Aldigier JC; Conte JJ; Grunfeld JP; Harper SJ; Meyer BH; Pauly N; Wilkinson R
    Br J Clin Pharmacol; 1993 Feb; 35(2):128-35. PubMed ID: 8443030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.
    Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
    J Rheumatol; 1993 Feb; 20(2):263-7. PubMed ID: 8474062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level.
    Takeuchi H; Matsuno N; Hirano T; Toraishi T; Konno O; Nakamura Y; Iwamoto H; Hama K; Unezaki S; Nagao T
    Transplant Proc; 2008 Sep; 40(7):2240-2. PubMed ID: 18790203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prednisolone half-life and T lymphocytes in renal allograft recipients.
    Walker KB; House AK; Maley MA; Potter JM
    Transplant Proc; 1985 Apr; 17(2):1679-81. PubMed ID: 3885504
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of uremia on pharmacokinetics and protein binding of prednisolone.
    Bergrem H
    Acta Med Scand; 1983; 213(5):333-7. PubMed ID: 6880855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered prednisolone pharmacokinetics in patients treated with rifampicin.
    Bergrem H; Refvem OK
    Acta Med Scand; 1983; 213(5):339-43. PubMed ID: 6880856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prednisolone protein binding in renal transplant patients.
    Reece PA; Disney AP; Stafford I; Shastry JC
    Br J Clin Pharmacol; 1985 Aug; 20(2):159-62. PubMed ID: 3899153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients.
    Tornatore KM; Biocevich DM; Reed K; Tousley K; Singh JP; Venuto RC
    Transplantation; 1995 Mar; 59(5):729-36. PubMed ID: 7886801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.
    Henderson RG; Wheatley T; English J; Chakraborty J; Marks V
    Br Med J; 1979 Jun; 1(6177):1534-6. PubMed ID: 380747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nature of complications in patients with pemphigus in long-term treatment with corticosteroid hormones].
    Khudoleeva AB
    Sov Med; 1974 Mar; 37(3):133-5. PubMed ID: 4846970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.